General Information of the Compound
Compound ID
CP0561835
Compound Name
3-[[1-(4-hydroxybutyl)benzimidazol-2-yl]methyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
    Show/Hide
Structure
Formula
C25H31N5O2
Molecular Weight
433.556
Canonical SMILES
OCCCCn1c(CN2CN(c3ccccc3)C3(CCNCC3)C2=O)nc2ccccc12
    Show/Hide
InChI
InChI=1S/C25H31N5O2/c31-17-7-6-16-29-22-11-5-4-10-21(22)27-23(29)18-28-19-30(20-8-2-1-3-9-20)25(24(28)32)12-14-26-15-13-25/h1-5,8-11,26,31H,6-7,12-19H2
    Show/Hide
InChIKey
HELWBRWUHUEZGG-UHFFFAOYSA-N
Physicochemical Property
logP
2.7373
Rotatable Bonds
7
Heavy Atom Count
32
Polar Areas
73.63
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
6
Complexity
32

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 145957010
ChEMBL ID
CHEMBL4162611
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00459, Fusion glycoprotein F0
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000668 HEp-2 Homo sapiens (Human)  1
1
EC50 > 50000 nM
   TI
   LI
   LO
   TS